Comparing AMN Healthcare Services (NYSE:AMN) & Atlantic International (NASDAQ:ATLN)

AMN Healthcare Services (NYSE:AMN) and Atlantic International (NASDAQ:ATLN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.

Risk and Volatility

AMN Healthcare Services has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, Atlantic International has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.

Profitability

This table compares AMN Healthcare Services and Atlantic International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-4.93%	15.22%	4.72%
Atlantic International	N/A	-298.20%	-42.32%

Insider & Institutional Ownership

99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by insiders. Comparatively, 22.3% of Atlantic International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares AMN Healthcare Services and Atlantic International”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.85 billion	0.28	-$146.98 million	($4.33)	-4.80
Atlantic International	$444.80 million	0.31	-$5.63 million	($3.96)	-0.59

Atlantic International has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Atlantic International, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations for AMN Healthcare Services and Atlantic International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	1	4	3	0	2.25
Atlantic International	0	0	0	0	0.00

AMN Healthcare Services presently has a consensus target price of $32.08, indicating a potential upside of 54.39%. Given AMN Healthcare Services’ stronger consensus rating and higher probable upside, analysts clearly believe AMN Healthcare Services is more favorable than Atlantic International.

About AMN Healthcare Services

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

About Atlantic International

Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.